Dashboard
Manage Tickers

OGN Organon & Co.

NYSE organon.com


$ 6.79 $ 0.18 (2.74 %)    

Friday, 31-Oct-2025 19:54:10 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 629.16 $ 3.02 (0.48 %)
DIA $ 475.58 $ 0.66 (0.14 %)
SPY $ 681.80 $ 2.23 (0.33 %)
TLT $ 90.21 $ -0.27 (-0.3 %)
GLD $ 368.20 $ -2.01 (-0.54 %)
$ 6.75
$ 6.61
$ 6.65 x 30
$ 6.94 x 30
$ 6.55 - $ 6.93
$ 6.18 - $ 18.19
8,050,608
na
1.75B
$ 0.43
$ 2.51
TBD
na
na ($ 0.09)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-06-2025 06-30-2025 10-Q
2 05-02-2025 03-31-2025 10-Q
3 02-28-2025 12-31-2024 10-K
4 11-01-2024 09-30-2024 10-Q
5 08-07-2024 06-30-2024 10-Q
6 05-03-2024 03-31-2024 10-Q
7 02-26-2024 12-31-2023 10-K
8 11-03-2023 09-30-2023 10-Q
9 08-09-2023 06-30-2023 10-Q
10 05-05-2023 03-31-2023 10-Q
11 02-27-2023 12-31-2022 10-K
12 11-04-2022 09-30-2022 10-Q
13 08-04-2022 06-30-2022 10-Q
14 05-06-2022 03-31-2022 10-Q
15 03-21-2022 12-31-2021 10-K
16 11-12-2021 09-30-2021 10-Q
17 08-16-2021 06-30-2021 10-Q
18 06-21-2021 03-31-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles
12 Health Care Stocks Moving In Monday's I...
10/27/2025 17:05:57

gold-falls-3-carters-shares-gain-after-q3-earnings
Gold Falls 3%; Carter's Shares Gain After ...
10/27/2025 17:03:23

Core News & Articles
12 Health Care Stocks Moving In Monday's P...
10/27/2025 12:06:22

organon-board-appoints-evp-and-head-of-manufacturing--supply-joseph-morrissey-as-interim-ceo-following-kevin-ali-resignation
Organon Board Appoints EVP And Head Of Man...
10/27/2025 11:38:31

Core News & Articles
Deputy Director Of The White House Domesti...
10/16/2025 20:13:59

- Reuters

Core News & Articles
President Trump Says EMD Serono Will Large...
10/16/2025 19:56:37

https://www.youtube.com/watch?v=xagrobF4q1k 

Core News & Articles
President Trump Says We Will Dramatically ...
10/16/2025 19:52:50

https://www.youtube.com/watch?v=xagrobF4q1k 

Core News & Articles
'White House Set To Announce Proposal Seek...
10/16/2025 16:53:04

https://www.nytimes.com/2025/10/16/us/politics/trump-ivf-fertility.html

henlius-and-organon-secure-european-commission-approval-for-bildyos-and-bilprevda-denosumab-biosimilars-to-prolia-and-xgeva-covering-all-indications-across-eu
Henlius And Organon Secure European Commis...
09/19/2025 10:03:36

fda-approves-henlius-and-organons-bildyos-and-bilprevda-biosimilars-to-amgens-prolia-and-xgeva-expanding-us-bone-health-treatment-options
FDA Approves Henlius And Organon's BILDYOS...
09/02/2025 09:37:57

organon-raises-fy2025-sales-guidance-from-6125b-6325b-to-6275b-6375b-vs-6223b-est
Organon Raises FY2025 Sales Guidance from ...
08/05/2025 11:31:12

Organon (NYSE:OGN) raises FY2025 sales outlook from $6.125 billion-$6.325 billion to $6.275 billion-$6.375 billion vs $6.223 bi...

organon-q2-adj-eps-100-beats-094-estimate-sales-1594b-beat-1552b-estimate
Organon Q2 Adj. EPS $1.00 Beats $0.94 Esti...
08/05/2025 11:30:45

Organon (NYSE:OGN) reported quarterly earnings of $1.00 per share which beat the analyst consensus estimate of $0.94 by 6.84 pe...

Core News & Articles
Earnings Scheduled For August 5, 2025
08/05/2025 08:32:54

a-look-ahead-organons-earnings-forecast
A Look Ahead: Organon's Earnings Forecast
08/04/2025 16:02:32

Core News & Articles
Live On CNBC, Jenny Harrington Announces S...
07/08/2025 16:50:07

organons-vtama-granted-strong-recommendation-by-american-academy-of-dermatology-in-updated-2025-guidelines-for-adult-atopic-dermatitis
Organon's VTAMA Granted Strong Recommendat...
07/07/2025 11:32:56

organons-phase-2-elena-proof-of-concept-study-of-og-6219-in-endometriosis-related-pain-did-not-meet-its-primary-efficacy-endpoint-discontinues-the-og-6219-clinical-development-program
Organon's Phase 2 Elena Proof-of-concept S...
07/02/2025 11:33:14

Organon (NYSE:OGN), a global healthcare company with a focus on women's health, today announced that the Phase 2 ELENA proo...

organons-phase-2-elena-proof-of-concept-study-evaluating-og-6219-did-not-meet-primary-efficacy-endpoint
Organon's Phase 2 ELENA Proof-of-Concept S...
07/02/2025 11:31:09

easy-income-portfolio-june-2025-update
Easy Income Portfolio: June 2025 Update
06/16/2025 14:20:25

samsung-bioepis-and-organon-say-fda-designates-hadlima-high--and-low-concentration-autoinjectors-and-high-concentration-prefilled-syringe-as-interchangeable-biosimilars-to-humira
Samsung Bioepis And Organon Say FDA Design...
05/27/2025 11:32:12

HADLIMA™ (adalimumab-bwwd) injection, 40 mg/0.4 mL & 40 mg/0.8 mL is now interchangeable with all high- and low-concentrati...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION